Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
Diluent only; Diluent only; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate dose of vaccine administered (Verbatim: Diluent only) and inappropriate preparation of medication (Verbatim: Diluent only). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK receipt date: 01-AUG-2025 The reporter wanted to know what should be done if a patient was given just the liquid component of Menveo 2 vial which led to inappropriate dose of vaccine administration and inappropriate preparation of medication. They reported a mal administration within an hour of the question being asked through the adverse event website so it had already been reported and they were not using this system to report. She just needed to know if the patient needs to be alerted and revaccinated.